The market size of the progressive supranuclear palsy treatment market is expected to experience significant growth in the coming years, as more research is conducted on the disease and new treatments ...
Progressive supranuclear palsy, or PSP, is a rare brain disease that causes problems with balance, eye movements and thinking ...
Drawing from UK Biobank data, Mass General Brigham researchers have uncovered specific health factors linked to higher or lower risk of developing progressive supranuclear palsy (PSP), a rare but ...
Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...
BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...
Early trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions ...
Rep. Jennifer Wexton (D-VA) announced that she will not seek reelection in 2024 after having been diagnosed with the rare degenerative disorder progressive supranuclear palsy. The 55-year-old ...
What are the early warning signs of Progressive Supranuclear Palsy? New UK Biobank research identifies depression, gut issues, and delirium as precursors to PSP.
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy –– ARV-102 ...
Civil rights leader Jesse Jackson died at the age of 84 after a long battle with a rare neurological disorder. Jackson suffered from progressive supranuclear palsy, which affects movement, balance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results